Systematic review / meta-analysis / 2009
Psyllium significantly lowered total and LDL cholesterol in a dose- and time-dependent manner in people with mild-to-moderate hypercholesterolemia.
A meta-analysis of 21 randomized placebo-controlled trials examined the effects of psyllium (3.0-20.4 g/day for >2 weeks) on serum lipids in mild-to-moderate hypercholesterolemia. Compared with placebo, psyllium reduced serum total cholesterol by 0.375 mmol/l (95% CI: 0.257-0.494 mmol/l) and LDL cholesterol by 0.278 mmol/l (95% CI: 0.213-0.312 mmol/l). Random-effects meta-regression identified a significant dose-response relationship between psyllium intake and reductions in both total and LDL cholesterol, as well as a time-dependent effect indicating total cholesterol was reduced more quickly than LDL cholesterol.
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- 1,717 subjects with mild-to-moderate hypercholesterolemia (1,030 psyllium, 687 placebo) across 21 studies
- What was measured
- Serum total cholesterol and LDL cholesterol levels
THE PAPER
Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials.
Wei ZH, Wang H, Chen XY, Wang BS, Rong ZX, Wang BS, Su BH, Chen HZ. Eur J Clin Nutr, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.